Finance entity
All 1 tracked stories fall under one category: markets. Of the tracked stories, 1 of 1 also mention JNJ-2113, the most common co-covered peer. Source depth averages 2 original sources per story, versus 2.8 across the same-window beat baseline. The 6 average consequence score is above the beat benchmark of 5.7 in the same window.
Last mentioned: Jun 14, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
All 1 tracked stories fall under one category: markets. Of the tracked stories, 1 of 1 also mention JNJ-2113, the most common co-covered peer. Source depth averages 2 original sources per story, versus 2.8 across the same-window beat baseline. The 6 average consequence score is above the beat benchmark of 5.7 in the same window. Rusfertide appears in 1 tracked Finance story from February 25, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 96 Finance stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Rusfertide. Shared-story counts are live from our verified record — not editorial picks.
Institutional Exit Revealed
13F filings reveal a $170 million divestment by a major institutional fund.
120% Gain Milestone
PTGX stock reaches a 120% gain milestone from its 52-week low.
J&J Partnership Milestone
Johnson & Johnson advances JNJ-2113 into late-stage trials, validating oral peptide tech.
Phase 3 Data Release
Positive Phase 3 data for rusfertide in polycythemia vera triggers initial stock rally.
Protagonist Therapeutics shares have soared 120% following clinical and regulatory milestones, but a recent $170 million institutional exit is raising questions about the stock's near-term ceiling. The move highlights a growing divergence between retail momentum and institutional profit-taking in the biotech sector.
Rusfertide is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
